Ozempic, Wegovy Shortage Is Officially Over Compounders given 60- to 90-day notice https://www.medpagetoday.com/endocrinology/diabetes/114324 The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand. The injectable formulation of the GLP-1 receptor […]
Filed under: General Problems | Leave a Comment »